ADVERTISEMENT
Podcasts
BTK Inhibitors Important in the Treatment Landscape of MCL
01/23/2020
Michael Wang, MD, The University of Texas MD Anderson Cancer Center, Houston, discusses the importance of Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of patients with mantle cell lymphoma (MCL).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement